Back to BlackRock, Inc.

GLUE
6 quarters

Position history for BlackRock, Inc.'s holdings in MONTE ROSA THERAPEUTICS INC

BlackRock, Inc. holds 5.6M shares of GLUE (MONTE ROSA THERAPEUTICS INC), worth $92.7M as of 2026-Q1. The position was increased (+34.8% shares). GLUE represents 0.0% of BlackRock, Inc.'s portfolio.

Current Value

$92.7M

Current Shares

5.6M

Total Value Change

+$66.1M

Total Shares Change

+1.8M

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q1
Latest
Increased
5.6M
+34.8%
$92.7M0.0%$17.96
39
2025-Q4
Increased
4.2M
+9.6%
$65.6M0.0%$15.97
32
2025-Q3
Decreased
3.8M
-0.8%
$28.3M0.0%$7.31
0
2025-Q2
Increased
3.8M
+2.1%
$17.3M0.0%$4.60
29
2025-Q1
Decreased
3.8M
-1.9%
$17.5M0.0%$5.10
0
2024-Q4
New
3.8M
-
$26.7M0.0%$7.02
40

Other major holders of GLUE: PRICE T ROWE ASSOCIATES INC /MD/, BAKER BROS. ADVISORS LP, Avoro Capital Advisors LLC

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used